These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2916952

  • 1. Aging and Alzheimer's disease. Altered cortical serotonergic binding.
    Sparks DL.
    Arch Neurol; 1989 Feb; 46(2):138-40. PubMed ID: 2916952
    [Abstract] [Full Text] [Related]

  • 2. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus.
    Sparks DL, DeKosky ST, Markesbery WR.
    Arch Neurol; 1988 Sep; 45(9):994-9. PubMed ID: 2901257
    [Abstract] [Full Text] [Related]

  • 4. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 5. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.
    Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR.
    J Neurochem; 1989 Dec; 53(6):1772-81. PubMed ID: 2553864
    [Abstract] [Full Text] [Related]

  • 6. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL, Thomas WE.
    Brain Res; 1988 Jun 01; 469(1-2):241-52. PubMed ID: 3401800
    [Abstract] [Full Text] [Related]

  • 7. Preservation of redox, polyamine, and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease.
    Palmer AM, Burns MA.
    J Neurochem; 1994 Jan 01; 62(1):187-96. PubMed ID: 8263519
    [Abstract] [Full Text] [Related]

  • 8. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.
    Kalaria RN, Andorn AC, Harik SI.
    Prog Clin Biol Res; 1989 Jan 01; 317():367-74. PubMed ID: 2557637
    [Abstract] [Full Text] [Related]

  • 9. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU.
    Exp Neurol; 1997 Jul 01; 146(1):91-103. PubMed ID: 9225742
    [Abstract] [Full Text] [Related]

  • 10. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration.
    Liu X, Erikson C, Brun A.
    Dementia; 1996 Jul 01; 7(3):128-34. PubMed ID: 8740626
    [Abstract] [Full Text] [Related]

  • 11. Ouabain binding in the human brain. Effects of Alzheimer's disease and aging.
    Harik SI, Mitchell MJ, Kalaria RN.
    Arch Neurol; 1989 Sep 01; 46(9):951-4. PubMed ID: 2549926
    [Abstract] [Full Text] [Related]

  • 12. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
    Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ.
    Neurology; 1988 May 01; 38(5):720-3. PubMed ID: 3362368
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN, Leake A.
    Psychoneuroendocrinology; 1990 May 01; 15(2):89-95. PubMed ID: 1972799
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome.
    Gulesserian T, Engidawork E, Cairns N, Lubec G.
    Neurosci Lett; 2000 Dec 15; 296(1):53-7. PubMed ID: 11099832
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
    Sparks DL, Markesbery WR, Slevin JT.
    Ann Neurol; 1986 Jun 15; 19(6):602-4. PubMed ID: 2425718
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.